American Trust reduced its position in shares of Livent Co. (NYSE:LTHM – Get Rating) by 14.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,298 shares of the company’s stock after selling 1,398 shares during the period. American Trust’s holdings in Livent were worth $254,000 at the end of the most recent quarter.
Other large investors also recently made changes to their positions in the company. First Personal Financial Services bought a new stake in Livent in the third quarter worth about $25,000. SeaCrest Wealth Management LLC bought a new stake in Livent in the second quarter worth about $30,000. Paragon Wealth Strategies LLC bought a new stake in Livent in the third quarter worth about $31,000. Sargent Bickham Lagudis LLC bought a new stake in Livent in the third quarter worth about $35,000. Finally, Almanack Investment Partners LLC. bought a new stake in Livent in the third quarter worth about $35,000. 90.62% of the stock is owned by institutional investors.
Livent Price Performance
Shares of NYSE:LTHM opened at $19.98 on Friday. The company has a 50 day moving average of $23.87 and a 200 day moving average of $26.77. The stock has a market cap of $3.59 billion, a P/E ratio of 14.80, a P/E/G ratio of 0.30 and a beta of 1.83. Livent Co. has a 12 month low of $18.26 and a 12 month high of $36.38. The company has a current ratio of 3.66, a quick ratio of 2.63 and a debt-to-equity ratio of 0.17.
Wall Street Analysts Forecast Growth
Several brokerages have commented on LTHM. Bank of America lowered shares of Livent from a “buy” rating to a “neutral” rating and lifted their price objective for the stock from $26.00 to $29.00 in a research report on Thursday, February 16th. Vertical Research upgraded shares of Livent from a “hold” rating to a “buy” rating and set a $30.00 target price for the company in a research note on Wednesday, January 4th. Piper Sandler reduced their target price on shares of Livent from $42.00 to $38.00 and set an “overweight” rating for the company in a research note on Thursday, December 15th. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Livent from $30.00 to $22.00 in a research note on Tuesday, January 10th. Finally, Citigroup lifted their target price on shares of Livent from $27.00 to $28.00 and gave the stock a “neutral” rating in a research note on Thursday, February 16th. Seven analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $30.21.
Livent Corp. engages in the production of performance lithium compounds. Its products include battery-grade lithium hydroxide, butyllithium, and purity lithium metal which are used in various performance applications. It operates through the following geographical segments: North America, Europe, Middle East, and Africa, Latin America, and Asia Pacific.
- Get a free copy of the StockNews.com research report on Livent (LTHM)
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
- Europe Raises Interest Rates, Should the Fed Follow?
Want to see what other hedge funds are holding LTHM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Livent Co. (NYSE:LTHM – Get Rating).
Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.